Modern prospects in the treatment of cancer of the breast and its metastasis. Medroxyprogesterone in massive doses as an alternative to polychemotherapy
Pannuti, F.
Minerva Chirurgica 32(19): 1211-1220
1977
ISSN/ISBN: 0026-4733 PMID: 593576 Document Number: 114623
Document emailed within 1 workday
Related Documents
Pannuti, F.; Pollutri, E.; Martoni, A.; Camera, P.; Lenaz, G.R. 1974: Medroxyprogesterone (map) in massive doses in oncology: effects of treatment on the ECG in a group of patients with advanced breast carcinoma Bollettino della Societa Italiana di Biologia Sperimentale 50(9): 557-561Pannuti, F.; Di Marco, A.R.; Martoni, A.; Fruet, F.; Strocchi, E.; Burroni, P.; Marraro, D. 1982: Medroxyprogesterone acetate (MAP) in high doses in the treatment of breast cancer in advanced stages Minerva Ginecologica 34(11): 977-979
Guarnieri, A.; Tucci, E.; D'Aniello, C.; Carli, A.; Mariani, L.; De Stefano, A.; Nardi, P. 1984: Oral route administration of medroxyprogesterone acetate (MAP) at high doses in the treatment of advanced breast cancer: clinical results Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 3(5): 320-323
Iba, T.; Kidokoro, A.; Fukunaga, M.; Sugiyama, K.; Aihara, N.; Suda, M. 2001: The efficacy of combination chemotherapy of 5'-deoxy-5-fluorouridine (5'-DFUR), cyclophosphamide (CPA) and medroxyprogesterone acetate (MPA) for bone metastasis in breast cancer patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(7): 973-977
Sturm, G.; Antal, E.; Schmidt Rhode, P.; Bauer, T.; Schulz K D. 1986: Medroxyprogesterone acetate and immunoreactive medroxyprogesterone acetate metabolites measured by two different selective radioimmunoassay antibodies in medroxyprogesterone acetate treated breast cancer patients Anticancer Research 6(3 Part A): 362
Zel'vin, B.M.; Belousov, A.P.; Batinov, I.N. 1970: The activity of several serum enzymes during treatment of lung cancer patients with massive doses of cyclophosphane Voprosy Onkologii 16(2): 26-29
McDaniel, E.B.; Pardthaisong, T. 1973: Incidence of breast nodules in women receiving multiple doses of medroxyprogesterone acetate Journal of Biosocial Science 5(1): 83-88
Mitsuyama, S.; Kuroda, Y.; Ohsato, K.; Nakamura, Y.; Murakami, F.; Nishikata, F.; Ikeda, S.; Egami, T.; Mori, A.; Ohe, H. 1996: Administration method and recurrence-preventing effect of medroxyprogesterone acetate (MPA) as a postoperative adjuvant endocrine therapy for stage III breast cancer. Kitakyushu Collaborative Study Group for Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(9): 1153-1160
Kashuro, V.A.; Glushkov, S.I.; Zheregelia, S.N. 2010: Cytoflavin in polychemotherapy of breast cancer Antibiotiki i Khimioterapiia 55(7-8): 30-33
Toi, M.; Taniguchi, T.; Hayashi, K.; Tominaga, T. 1995: The effect of combination treatment consisted of 5'-deoxy-5-fluorouridine and medroxyprogesterone acetate for recurrent breast cancer patient Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(6): 799-804
Jiang, J.; Xia, M.; Feng, J.-B.; Kong, B.-H. 2007: Inhibitory effect of breast cancer metastasis suppressor l gene on metastasis of human ovarian cancer cell in vitro and in vivo Zhonghua Fu Chan Ke Za Zhi 42(6): 398-402
Takatsuka, Y.; Katoh, T.; Tsumura, I.; Kobayakawa, K.; Kawahara, T. 1992: Successful treatment of disseminated breast cancer with combination therapy of 5'-deoxy-5'-fluorouridine (5'-DFUR), medroxyprogesterone acetate (MPA) and cyclophosphamide (CPA) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(1): 107-110
Tajima, T. 2003: Prospects for standardization of surgical treatment for breast cancer Nihon Geka Gakkai Zasshi 104(5): 427-431
Hayes, D.F.; Henderson, I.C.; Shapiro, C.L. 1995: Treatment of metastatic breast cancer: present and future prospects Seminars in Oncology 22(2 Suppl 5: 5
Nakamura, O.; Matsutani, M.; Nagashima, T.; Ueki, K.; Nakamura, M. 1989: The treatment of brain metastasis from breast cancer Gan no Rinsho. Japan Journal of Cancer Clinics 35(9): 979-982
Marín Gómez, L.Miguel.; Jiménez Romero, C.; Pérez Saborido, B.; González-Pinto Arrillaga, I.; Loinaz Segurola, C.; Ortiz Johansson, C.; Ferrero Celemin, E.; Moreno González, E. 2004: Surgical treatment of liver metastasis from breast cancer Hepato-Gastroenterology 51(56): 586-588
Baronti, G.; Terreni, F.; Del Corso, P.; Antonelli, G.C. 1972: Unusual development of massive destruction of the squama occipitalis by breast neoplasm metastasis Minerva Medica 63(91): 5020-5023
Kanaev, S.V.; Krivorot'ko, P.V.; Novikov, S.N.; Semiglazov, V.F.; Semiglzova, T.I.; Turkevich, E.A.; Zhukova, L.A.; Klimashevskiĭ, V.F.; Ivantsov, A.O.; Donskikh, R.V.; Klimenko, V.V.; Briantseva, Z.V. 2013: Effectiveness of mammary scintigraphy for determining the results of neoadjuvant polychemotherapy in breast cancer Voprosy Onkologii 59(3): 328-333
Henderson, J.W.; Donatelle, R.J. 2004: Complementary and alternative medicine use by women after completion of allopathic treatment for breast cancer Alternative Therapies in Health and Medicine 10(1): 52-57
Cheng, C.; Komljenovic, D.; Pan, L.; Dimitrakopoulou-Strauss, A.; Strauss, L.; Bäuerle, T. 2011: Evaluation of treatment response of cilengitide in an experimental model of breast cancer bone metastasis using dynamic PET with 18F-FDG Hellenic Journal of Nuclear Medicine 14(1): 15-20